Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meriggi

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal De Chirurgie|June 1, 1989
[Rejection of discordant xenografts of the liver and heart]A Settaf, F Meriggi, P Gane, et al.
Il Giornale Di Chirurgia|November 1, 1988
Liver transplantation in the rat: different personal techniques using cuffs for venous vascular anastomosesF Meriggi, G Morone, A Settaf, et al.
Transplantation Proceedings|February 1, 1989
Prolongation of heart xenograft survival in the rat: effectiveness of cyclosporine in preventing early xenoantibody rebound after membrane plasmapheresisJ Van de Stadt, F Meriggi, B Vendeville, et al.
Tumori|April 30, 1991
Mitomycin-C, adriamycin, 5-fluorouracil and leucovorin (L-FAM2) in the treatment of advanced gastric cancer: a phase II studyA Zaniboni, E Simoncini, P Marpicati, et al.
Transplantation Proceedings|February 1, 1987
Delayed rejection of liver xenografts compared to heart xenografts in the ratA Settaf, F Meriggi, J Van de Stadt, et al.
Anti-Cancer Drugs|October 1, 1995
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapyA Contu, N Olmeo, S Piro, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluorouracil, high-dose folinic acid, low-dose alpha-2b interferon and dipyridamole in the treatment of advanced colorectal cancer. A pilot studyA Zaniboni, P Marpicati, E Simoncini, et al.
Tumori|November 1, 1995
Mitomycin-C and lonidamine as second-line therapy for colorectal cancer: a phase II studyA Zaniboni, F Meriggi, A Alghisi, et al.
Minerva Medica|July 1, 1989
[Bronchogenic carcinoma invading the thoracic wall. The results of surgical treatment]E Forni, G Volpato, F Meriggi, et al.
Hematological Oncology|May 1, 1991
A phase II trial of ProMACE-CytaBOM in previously untreated non-Hodgkin's lymphoma of intermediate- or high-grade histologyG Rossi, M R Mariano, G Arcangeli, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal De Chirurgie|June 1, 1989
[Rejection of discordant xenografts of the liver and heart]A Settaf, F Meriggi, P Gane, et al.
Il Giornale Di Chirurgia|November 1, 1988
Liver transplantation in the rat: different personal techniques using cuffs for venous vascular anastomosesF Meriggi, G Morone, A Settaf, et al.
Transplantation Proceedings|February 1, 1989
Prolongation of heart xenograft survival in the rat: effectiveness of cyclosporine in preventing early xenoantibody rebound after membrane plasmapheresisJ Van de Stadt, F Meriggi, B Vendeville, et al.
Tumori|April 30, 1991
Mitomycin-C, adriamycin, 5-fluorouracil and leucovorin (L-FAM2) in the treatment of advanced gastric cancer: a phase II studyA Zaniboni, E Simoncini, P Marpicati, et al.
Transplantation Proceedings|February 1, 1987
Delayed rejection of liver xenografts compared to heart xenografts in the ratA Settaf, F Meriggi, J Van de Stadt, et al.
Anti-Cancer Drugs|October 1, 1995
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapyA Contu, N Olmeo, S Piro, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluorouracil, high-dose folinic acid, low-dose alpha-2b interferon and dipyridamole in the treatment of advanced colorectal cancer. A pilot studyA Zaniboni, P Marpicati, E Simoncini, et al.
Tumori|November 1, 1995
Mitomycin-C and lonidamine as second-line therapy for colorectal cancer: a phase II studyA Zaniboni, F Meriggi, A Alghisi, et al.
Minerva Medica|July 1, 1989
[Bronchogenic carcinoma invading the thoracic wall. The results of surgical treatment]E Forni, G Volpato, F Meriggi, et al.
Hematological Oncology|May 1, 1991
A phase II trial of ProMACE-CytaBOM in previously untreated non-Hodgkin's lymphoma of intermediate- or high-grade histologyG Rossi, M R Mariano, G Arcangeli, et al.
Pageof 8